1. Home
  2. RTX vs MRK Comparison

RTX vs MRK Comparison

Compare RTX & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RTX Corporation

RTX

RTX Corporation

HOLD

Current Price

$183.67

Market Cap

234.3B

Sector

Industrials

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$105.17

Market Cap

260.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RTX
MRK
Founded
1934
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.3B
260.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RTX
MRK
Price
$183.67
$105.17
Analyst Decision
Buy
Buy
Analyst Count
14
15
Target Price
$179.36
$111.93
AVG Volume (30 Days)
4.3M
14.0M
Earning Date
01-27-2026
02-03-2026
Dividend Yield
1.48%
3.23%
EPS Growth
38.64
58.08
EPS
4.87
7.56
Revenue
$85,988,000,000.00
$64,235,000,000.00
Revenue This Year
$8.82
$1.98
Revenue Next Year
$6.24
$4.94
P/E Ratio
$37.66
$13.93
Revenue Growth
8.79
1.68
52 Week Low
$112.27
$73.31
52 Week High
$188.00
$107.59

Technical Indicators

Market Signals
Indicator
RTX
MRK
Relative Strength Index (RSI) 61.03 63.73
Support Level $176.54 $96.79
Resistance Level $188.00 $107.59
Average True Range (ATR) 2.80 2.06
MACD 0.37 0.16
Stochastic Oscillator 68.28 77.08

Price Performance

Historical Comparison
RTX
MRK

About RTX RTX Corporation

RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure across three segments, mostly as a supplier to commercial aerospace and to the defense market: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: